Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

22.07
Delayed Data
As of Jul 27
 +0.70 / +3.28%
Today’s Change
9.51
Today|||52-Week Range
23.30
+64.21%
Year-to-Date

Today’s Trading

Previous close21.37
Today’s open21.47
Day’s range21.07 - 22.22
Volume371,150
Average volume (3 months)569,465
Market cap$1.1B
Dividend yield--
Data as of 07/27/2016

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+126.53%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)+18.34%
P/E ratio64.3
Price/Sales4.76
Price/Book9.10

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...+1.25+5.47%
INSYINSYS Therapeutics I...+0.33+2.13%
MGNXMacroGenics Inc+0.99+3.42%
DERMDermira Inc+1.98+6.11%
Data as of 07/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers

Search for Jobs